← Back to Discover
TFG Asset Management GP Ltd
Period ended Jun 30, 2026 · Latest filing Aug 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $635,063,221
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- UIPATH INC · CL A · 90364P105 · shares: $336,426,500
- KOLIBRI GLOBAL ENERGY INC · COM NEW · 50043K406 · shares: $33,845,142
- AUTOLUS THERAPEUTICS LTD · SPON ADS · 05280R100 · shares: $15,200,000
- LYFT INC · CL A COM · 55087P104 · shares: $14,610,000
- DEFINIUM THERAPEUTICS INC · COM SHS · 24477V105 · shares: $13,500,010
- WORKIVA INC · COM CL A · 98139A105 · shares: $12,127,500
- SPRINKLR INC · CL A · 85208T107 · shares: $11,352,000
- MBX BIOSCIENCES INC · COM · 55287L101 · shares: $11,235,574
- ALKAMI TECHNOLOGY INC · COM · 01644J108 · shares: $10,877,146
- CELLDEX THERAPEUTICS INC NEW · COM NEW · 15117B202 · shares: $10,807,310
Reported holdings
43 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| UIPATH INC | CL A | 90364P105 | — | 22,450,000 shares | $244,031,500 |
| UIPATH INC | CL A | 90364P105 | — | 5,264,462 shares | $57,224,702 |
| UIPATH INC | CL A | 90364P105 | — | 3,235,538 shares | $35,170,298 |
| KOLIBRI GLOBAL ENERGY INC | COM NEW | 50043K406 | — | 4,154,954 shares | $20,575,744 |
| AUTOLUS THERAPEUTICS LTD | SPON ADS | 05280R100 | — | 9,500,000 shares | $15,200,000 |
| LYFT INC | CL A COM | 55087P104 | — | 1,000,000 shares | $14,610,000 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 286,990 shares | $13,500,010 |
| KOLIBRI GLOBAL ENERGY INC | COM NEW | 50043K406 | — | 2,679,550 shares | $13,269,398 |
| WORKIVA INC | COM CL A | 98139A105 | — | 250,000 shares | $12,127,500 |
| SPRINKLR INC | CL A | 85208T107 | — | 2,200,000 shares | $11,352,000 |
| MBX BIOSCIENCES INC | COM | 55287L101 | — | 203,543 shares | $11,235,574 |
| ALKAMI TECHNOLOGY INC | COM | 01644J108 | — | 600,284 shares | $10,877,146 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 290,441 shares | $10,807,310 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 570,311 shares | $10,670,519 |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | — | 130,484 shares | $10,635,751 |
| PHARVARIS N V | COM | N69605108 | — | 295,627 shares | $10,222,782 |
| ALKERMES PLC | SHS | G01767105 | — | 189,979 shares | $9,953,950 |
| IMMUNOVANT INC | COM | 45258J102 | — | 255,934 shares | $9,861,137 |
| AXSOME THERAPEUTICS INC. | COM | 05464T104 | CALL | 35,000 shares | $8,566,950 |
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | — | 764,256 shares | $8,391,531 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 356,657 shares | $7,921,352 |
| IONIS PHARMACEUTICALS INC | COM | 462222100 | — | 97,173 shares | $7,704,847 |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | — | 205,579 shares | $7,629,037 |
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | — | 201,036 shares | $7,319,721 |
| KRYSTAL BIOTECH INC | COM | 501147102 | — | 19,668 shares | $7,310,006 |
| ANNEXON INC | COM | 03589W102 | — | 1,242,455 shares | $7,094,418 |
| CELCUITY INC | COM | 15102K100 | — | 64,110 shares | $6,707,188 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 86,996 shares | $6,073,191 |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | — | 297,926 shares | $5,350,751 |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | — | 167,875 shares | $4,247,238 |
| WARNER BROS DISCOVERY INC | COM SER A | 934423104 | — | 154,794 shares | $4,126,808 |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | CALL | 100,000 shares | $3,339,000 |
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | CALL | 300,000 shares | $3,294,000 |
| CUE BIOPHARMA INC | COM | 22978P205 | — | 93,819 shares | $2,960,928 |
| SNOWFLAKE INC | COM SHS | 833445109 | — | 10,000 shares | $2,545,000 |
| WARNER BROS DISCOVERY INC | COM SER A | 934423104 | — | 95,206 shares | $2,538,192 |
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | CALL | 250,300 shares | $2,445,431 |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | — | 400,000 shares | $2,116,000 |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | CALL | 50,000 shares | $1,855,500 |
| TECTONIC THERAPEUTIC INC | COM | 878972108 | — | 46,516 shares | $1,598,988 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | — | 56,052 shares | $1,356,458 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | CALL | 75,100 shares | $1,092,705 |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | CALL | 8,500 shares | $152,660 |